InMed Pharmaceuticals, Inc. (INM)
1.31
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
InMed Pharmaceuticals Gross Profit (TTM) : -0.1222M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1222M |
| March 31, 2026 | 0.0075M |
| December 31, 2025 | 0.0905M |
| September 30, 2025 | 0.3943M |
| June 30, 2025 | 0.4962M |
| March 31, 2025 | 0.6775M |
| December 31, 2024 | 0.8683M |
| September 30, 2024 | 0.8846M |
| June 30, 2024 | 0.501M |
| March 31, 2024 | 1.603M |
| December 31, 2023 | 1.513M |
| September 30, 2023 | 1.159M |
| June 30, 2023 | 1.140M |
| March 31, 2023 | 0.0933M |
| December 31, 2022 | 0.0829M |
| September 30, 2022 | 0.0646M |
| June 30, 2022 | 0.0683M |
| March 31, 2022 | -0.0762M |
| December 31, 2021 | -0.1654M |
| September 30, 2021 | -0.1839M |
| June 30, 2021 | -0.1834M |
| March 31, 2021 | -0.1917M |
| December 31, 2020 | -0.1902M |
| September 30, 2020 | -0.1903M |
| June 30, 2020 | -0.1738M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1487M |
| December 31, 2019 | -0.1241M |
| September 30, 2019 | -0.103M |
| June 30, 2019 | -0.0939M |
| March 31, 2019 | -0.0953M |
| December 31, 2018 | -0.0953M |
| September 30, 2018 | -0.0953M |
| June 30, 2018 | -0.0927M |
| March 31, 2018 | -0.0865M |
| December 31, 2017 | -0.0847M |
| September 30, 2017 | -0.0777M |
| June 30, 2017 | -0.0737M |
| March 31, 2017 | -0.0734M |
| December 31, 2016 | -0.0514M |
| September 30, 2016 | -0.0507M |
| June 30, 2016 | -0.0499M |
| March 31, 2016 | -0.0501M |
| December 31, 2015 | -0.0671M |
| September 30, 2015 | -0.0697M |
| June 30, 2015 | -0.0809M |
| March 31, 2015 | -0.0636M |
| December 31, 2014 | -0.0466M |
| September 30, 2014 | -0.0278M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| NervGen Pharma Corp. | -0.0404M |
| Milestone Pharmaceuticals, Inc. | 2.125M |
| Clearmind Medicine, Inc. | -0.0526M |
| Lexaria Bioscience Corp. | 0.095M |
| Target Group, Inc. (Canada) | 0.4683M |